TGAオーストラリア供給不足情報（2025年2月10日～2月16日）

ホーム > 供給不足情報 > 海外医薬品不足状況 > オーストラリア > TGAオーストラリア供給不足情報（2025年2月10日～2月16日）
Active ingredientsDosage formQuantity of active ingredientsShortage statusAvailabilityReasonLast updated
fentanylDrug delivery system, transdermal4.2 mgAnticipatedAvailableUnexpected increase in demand due to other sponsors unable to supply14/02/2025
morphine hydrochloride trihydrateInjection, solution10 mg/mLResolvedAvailableManufacturing14/02/2025
leuprorelin acetate~bicalutamideInjection, modified release~Tablet, film coated22.5 mg~50 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability14/02/2025
leuprorelin acetate~bicalutamideInjection, modified release~Tablet, film coated7.5 mg~50 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability14/02/2025
leuprorelin acetate~bicalutamideInjection, modified release~Tablet, film coated22.5 mg~50 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability14/02/2025
mupirocinOintment20 mg/gCurrentLimited AvailabilityUnexpected increase in consumer demand14/02/2025
ethanol absolute~carmustineDiluent, not applicable~Injection, powder for3 mL~100 mgAnticipatedAvailableUnexpected increase in demand due to other sponsors unable to supply14/02/2025
tramadol hydrochlorideTablet, modified release200 mgResolvedAvailableManufacturing13/02/2025
glyceryl trinitrateInjection, concentrated50 mgCurrentLimited AvailabilityManufacturing13/02/2025
levetiracetamTablet, film coated250 mgResolvedAvailableManufacturing13/02/2025
levodopa~entacapone~carbidopa monohydrateTablet, film coated125 mg~200 mg~33.75 mgAnticipatedAvailableManufacturing13/02/2025
pramipexole dihydrochloride monohydrateTablet.25 mgAnticipatedAvailableUnexpected increase in consumer demand13/02/2025
daptomycinInjection, powder for500 mgCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply13/02/2025
melatoninOral Liquid, solution1 mg/mLCurrentLimited AvailabilityUnexpected increase in consumer demand13/02/2025
heparin sodiumInjection, solution10 IU/mLCurrentUnavailableManufacturing13/02/2025
tobramycinInjection, solution80 mgResolvedAvailableManufacturing12/02/2025
amlodipine besilateTablet, uncoated6.94 mgResolvedAvailableManufacturing12/02/2025
topiramateTablet, film coated200 mgResolvedAvailableManufacturing12/02/2025
letrozoleTablet, film coated2.5 mgCurrentUnavailableManufacturing12/02/2025
vinblastine sulfateInjection, solution1 mg/mLCurrentLimited AvailabilityManufacturing12/02/2025
oxytocinInjection, solution10 IU/mLAnticipatedAvailableManufacturing12/02/2025
tadalafilTablet, film coated20 mgResolvedAvailableManufacturing12/02/2025
hydrochlorothiazide~olmesartan medoxomilTablet12.5 mg~20 mgCurrentUnavailableManufacturing12/02/2025
dosulepin (dothiepin) hydrochlorideTablet, film coated75 mgCurrentLimited AvailabilityManufacturing12/02/2025
TrastuzumabInjection, powder for156 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability12/02/2025
mefenamic acidCapsule, hard250 mgAnticipatedAvailableTransport / Logistic issues / Storage capacity issues12/02/2025
naloxone hydrochloride dihydrateSpray, nasal2.2 mg/actuationCurrentLimited AvailabilityUnexpected increase in consumer demand12/02/2025
lurasidone hydrochlorideTablet, film coated80 mgCurrentUnavailableManufacturing12/02/2025
atorvastatin calcium trihydrateTablet, film coated86.751 mgCurrentLimited AvailabilityManufacturing12/02/2025
sitagliptin hydrochloride monohydrateTablet, film coated109 mgCurrentUnavailableManufacturing12/02/2025
sitagliptin hydrochloride monohydrateTablet, film coated54.5 mgCurrentUnavailableManufacturing12/02/2025
sitagliptin hydrochloride monohydrateTablet, film coated27.25 mgCurrentUnavailableManufacturing12/02/2025
midazolamInjection, solution5 mg/mLCurrentLimited AvailabilityUnexpected increase in consumer demand12/02/2025
fluorouracilInjection, solution50 mg/mLCurrentUnavailableUnexpected increase in demand due to other sponsors unable to supply12/02/2025
balsalazide sodiumCapsule750 mgAnticipatedAvailableManufacturing12/02/2025
nizatidineCapsule150 mgAnticipatedAvailableManufacturing12/02/2025
exemestaneTablet, film coated25 mgCurrentLimited AvailabilityManufacturing11/02/2025
acetylcysteineInjection, concentrated2 gAnticipatedAvailableUnexpected increase in demand due to other sponsors unable to supply11/02/2025
armodafinilTablet, uncoated50 mgAnticipatedAvailableManufacturing11/02/2025
fluorouracilInjection, solution50 mg/mLCurrentUnavailableManufacturing11/02/2025
ezetimibe~atorvastatin calcium trihydrateTablet, film coated10 mg~10.341 mgCurrentUnavailableManufacturing11/02/2025
BevacizumabInjection, concentrated25 mg/mLCurrentUnavailableCommercial Changes / Commercial viability11/02/2025
mupirocin calciumCream21.5 mg/gCurrentLimited AvailabilityManufacturing11/02/2025
ioversolInjection, solution509 mg/mLDiscontinuedUnavailableCommercial Changes / Commercial viability11/02/2025
ioversolInjection, solution678 mg/mLDiscontinuedUnavailableManufacturing11/02/2025
ioversolInjection, solution678 mg/mLDiscontinuedUnavailableUnexpected increase in demand due to other sponsors unable to supply11/02/2025
carboplatinInjection, solution10 mg/mLCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply11/02/2025
ioversolInjection, solution741 mg/mLDiscontinuedUnavailableManufacturing11/02/2025
ioversolInjection, solution678 mg/mLDiscontinuedUnavailableManufacturing11/02/2025
ioversolInjection, solution741 mg/mLDiscontinuedUnavailableManufacturing11/02/2025
ioversolInjection, solution741 mg/mLDiscontinuedUnavailableManufacturing11/02/2025
ethinylestradiol~norethisteroneTablet, uncoated36 microgram~500 microgramAnticipatedAvailableUnexpected increase in consumer demand11/02/2025
ioversolInjection, solution678 mg/mLDiscontinuedUnavailableManufacturing11/02/2025
primidoneTablet, uncoated250 mgAnticipatedAvailableManufacturing10/02/2025
trihexyphenidyl (benzhexol) hydrochlorideTablet, uncoated2 mgAnticipatedAvailableUnexpected increase in consumer demand10/02/2025
neostigmine methylsulfateInjection, solution2.5 mgCurrentUnavailableManufacturing10/02/2025
ribociclib succinateTablet, film coated254.4 mgAnticipatedAvailableTransport / Logistic issues / Storage capacity issues10/02/2025
montelukast sodiumTablet, chewable5.2 mgCurrentUnavailableManufacturing10/02/2025
cisatracurium besilateInjection, solution13.4 mgAnticipatedAvailableManufacturing10/02/2025
pioglitazone hydrochlorideTablet, uncoated16.53 mgAnticipatedAvailableCommercial Changes / Commercial viability10/02/2025
pioglitazone hydrochlorideTablet, uncoated33.06 mgAnticipatedAvailableCommercial Changes / Commercial viability10/02/2025
oxycodone hydrochlorideOral Liquid, solution1 mg/mLResolvedAvailableUnexpected increase in consumer demand10/02/2025
dinoprostoneGel.6667 mg/gResolvedAvailableManufacturing10/02/2025
2025年2月17日
このページの先頭へ戻る